Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...
The Melanoma Institute of Australia (MIA) previously developed a risk calculator for sentinel lymph node (SLN) metastasis risk to help clinicians and patients with primary cutaneous melanoma decide ...
The SenSzi (GBG80) Trial 1 has assessed the contribution of information derived from lymphoscintigraphy in improving the performance of the sentinel lymph node (SLN) biopsy procedure in cN0 breast ...
Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations Genes with functional roles in melanoma metastasis were discovered by analysis of next-generation sequencing ...
Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...
Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results